Skip to content

ESLAW

Estrella Immunopharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.07
+2.71%
Ask drillr

Next report

Analyst consensus

Next report date
Dec 2, 2026
EPS estimate
-$0.08
Revenue estimate

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$0.05
EPS estimate
-$0.09
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
1
EPS in line (12Q)
0
Avg surprise (4Q)
+51.6%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$0.09-$0.05Beat 44.44%
May 18, 2026-$0.08-$0.05Beat 40.48%
Mar 18, 2026-$0.18-$0.02Beat 91.03%
Nov 12, 2025-$0.19-$0.13Beat 30.61%
Aug 12, 2025-$0.07-$0.15Miss -119.03%
May 14, 2025-$0.11-$0.06Beat 47.14%
Nov 14, 2024-$0.09
Sep 26, 2024-$0.11

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026